• Latest Posts

Boehringer kindles NASH treatments with Pharmaxis’ drug acquisition

Novo Nordisk Takes on One of the World’s Biggest Markets: Obesity

Succesfull Phase II for Novo Nordisk’s new diabetes treatment

Novo Nordisk invests €104M in new laboratory for Diabetes

Once a Week Insulin Shot : Novo Nordisk’s new Idea

ADVERTISEMENT